Correlation Between Derwent London and AstraZeneca PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Derwent London and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Derwent London and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Derwent London PLC and AstraZeneca PLC, you can compare the effects of market volatilities on Derwent London and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Derwent London with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Derwent London and AstraZeneca PLC.

Diversification Opportunities for Derwent London and AstraZeneca PLC

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Derwent and AstraZeneca is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Derwent London PLC and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and Derwent London is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Derwent London PLC are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of Derwent London i.e., Derwent London and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between Derwent London and AstraZeneca PLC

Assuming the 90 days trading horizon Derwent London is expected to generate 4.82 times less return on investment than AstraZeneca PLC. But when comparing it to its historical volatility, Derwent London PLC is 1.43 times less risky than AstraZeneca PLC. It trades about 0.06 of its potential returns per unit of risk. AstraZeneca PLC is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  1,093,800  in AstraZeneca PLC on November 18, 2024 and sell it today you would earn a total of  77,000  from holding AstraZeneca PLC or generate 7.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Derwent London PLC  vs.  AstraZeneca PLC

 Performance 
       Timeline  
Derwent London PLC 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Derwent London PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Derwent London is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
AstraZeneca PLC 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, AstraZeneca PLC exhibited solid returns over the last few months and may actually be approaching a breakup point.

Derwent London and AstraZeneca PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Derwent London and AstraZeneca PLC

The main advantage of trading using opposite Derwent London and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Derwent London position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.
The idea behind Derwent London PLC and AstraZeneca PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios